Scalp Psoriasis: Symptoms, Causes & Treatment Options

What Is Scalp Psoriasis?

Scalp psoriasis is a chronic, immune-mediated inflammatory skin disorder that produces raised, well-demarcated red plaques covered with thick silvery-white scale on the scalp. It is not a separate disease from psoriasis — it is plaque psoriasis manifesting on the scalp, and it follows the same pathophysiological mechanism as psoriasis anywhere on the body.

Psoriasis itself affects approximately 7.5 million people in the United States, and at least 50% of those with plaque psoriasis experience scalp involvement at some point. For some people, the scalp is the only site affected; for others, scalp lesions accompany plaques on the elbows, knees, lower back, and nails. The condition is chronic and relapsing, meaning periods of remission are typically followed by flares.

How Scalp Psoriasis Develops: The Immune Mechanism

Understanding the cause of scalp psoriasis requires understanding what psoriasis is: an autoimmune process in which the immune system generates a chronic inflammatory signal that drives keratinocytes (skin cells) to divide far too rapidly.

In healthy skin, new keratinocytes mature and reach the surface over 28–30 days before they shed invisibly. In psoriatic skin, this cycle collapses to just 3–4 days. The skin cannot shed cells fast enough, so they accumulate on the surface as the characteristic thick, white-silvery scale.

The immune cascade responsible centers on the IL-23/IL-17 axis:

1. Dendritic cell activation — in genetically predisposed individuals, environmental or internal triggers activate inflammatory myeloid dendritic cells in the skin.
2. IL-23 production — activated dendritic cells release IL-23, which drives the maturation of naïve T-cells into Th17 cells.
3. IL-17A release — Th17 cells produce IL-17A, the principal effector cytokine of psoriatic disease, alongside TNF-α, IFN-γ, and IL-22.
4. Keratinocyte hyperproliferation — these cytokines act on keratinocytes, causing them to proliferate abnormally, recruit more immune cells, and release antimicrobial peptides that sustain the inflammatory loop.

This positive feedback cycle between immune cells and keratinocytes maintains the chronic plaques. Genetic variants in genes regulating the IL-23/IL-17 pathway — including IL-23R, IL-12B, and STAT3 — are strongly associated with psoriasis susceptibility, explaining why the condition runs in families.

Symptoms of Scalp Psoriasis

Scalp psoriasis can range from a single small patch to plaques covering the entire scalp. It frequently extends beyond the hairline onto the forehead, nape of the neck, and behind the ears.

Core symptoms

• Silvery-white scale overlying red, thickened plaques — the most distinctive feature. Scale may accumulate as thick white flakes that shed onto clothing, resembling dandruff but larger and more adherent.
• Itching — one of the most common and distressing symptoms. Severity ranges from mild to intense itching that disrupts sleep.
• Burning or soreness — plaques can feel tender and sore to the touch.
• Bleeding — scratching damages the skin surface and causes pinpoint bleeding, known as the Auspitz sign.
• Temporary hair loss — scratching or forcefully removing scale can disrupt hair follicles; this is almost always reversible once the condition is treated.
• Flaking — shed scale may appear as visible flakes in hair or on dark clothing, often confused with dandruff.

Disease course

Scalp psoriasis is chronic and fluctuating. Many people experience identifiable flare triggers that worsen symptoms, while periods of relative remission may follow adequate treatment or spontaneously.

Common Triggers

Psoriasis flares are driven by both internal and external factors. On the scalp, common triggers include:

Identifying and minimizing personal triggers is a valuable adjunct to medical treatment, though it does not replace it.

Diagnosis

Scalp psoriasis is typically diagnosed clinically by a dermatologist, based on the characteristic appearance of well-demarcated red plaques with thick silvery scale. The distribution — scalp, hairline, behind the ears, nape — is also diagnostically informative.

Dermoscopy (trichoscopy) may be used to examine the scalp more closely: key trichoscopic features of psoriasis include red dots, hairpin vessels, and red globular rings — patterns distinct from those seen in seborrheic dermatitis.

Skin biopsy is occasionally performed when the diagnosis is uncertain, particularly when distinguishing scalp psoriasis from seborrheic dermatitis. Histopathological features specific to psoriasis include mounds of parakeratosis with neutrophils, spongiform micropustules of Kogoj, and evenly elongated rete ridges.

The Psoriasis Scalp Severity Index (PSSI) is a validated clinical scoring tool used to assess and monitor disease severity in clinical practice and research.

Treatment Options

Treatment is tailored to disease severity and scalp coverage. Most people start with topical therapies; moderate-to-severe or refractory disease warrants systemic treatment.

First-line: Topical Treatments

Topical corticosteroids are the most commonly prescribed treatment for scalp psoriasis in both children and adults. They reduce inflammation, redness, itch, and scaling rapidly. Formulations include shampoos, foams, gels, solutions, and oils — formats designed to penetrate the hair-bearing scalp more effectively than cream. Strong corticosteroids (e.g., clobetasol propionate shampoo) may be used daily for up to four weeks, then intermittently to maintain clearance.

Vitamin D analogues (calcipotriol/calcitriol) normalize keratinocyte proliferation and reduce inflammation. Used alone, they are less potent than strong corticosteroids; combined with betamethasone dipropionate (as in licensed fixed-dose combination gels), they outperform either agent alone for both short-term clearance and long-term maintenance.

Coal tar reduces itch and helps normalize the rate of abnormal skin cell production. Available OTC in shampoos at low concentrations (0.5%–1% in the US) and by prescription at higher concentrations. It has an unpleasant smell and can stain hair and fabric.

Salicylic acid (2%–4%) acts as a keratolytic — it softens and loosens scale, making it easier to remove and improving the penetration of other treatments applied afterward. It is most useful as a preparatory step rather than a standalone therapy.

Tazarotene (a retinoid) and calcineurin inhibitors (tacrolimus, pimecrolimus) are used in selected cases.

Second-line: Phototherapy

Targeted UVB phototherapy using a handheld UVB comb device can deliver light directly through hair to affected scalp skin. It is more practical than traditional broadband UVB for scalp-limited disease and is used when topical therapies are insufficient.

Third-line: Systemic Treatments

For moderate-to-severe scalp psoriasis or psoriasis affecting significant body surface area:

Conventional systemics:

• Methotrexate — inhibits immune cell proliferation; taken orally or by injection weekly.
• Cyclosporine — a calcineurin inhibitor that suppresses T-cell activity; used for rapid disease control but not recommended for long-term use due to renal and cardiovascular risks.
• Acitretin — an oral retinoid that normalizes keratinocyte differentiation; useful particularly for pustular variants.
• Apremilast — an oral phosphodiesterase-4 inhibitor with a favorable safety profile, suitable for patients in whom biologics or immunosuppressants are inappropriate.

Biologic agents target specific immune mediators in the IL-23/IL-17 pathway:

A 2025 network meta-analysis of RCTs found secukinumab 300 mg Q4W to have the highest PSSI-response SUCRA (0.991) among biologic and non-biologic therapies for scalp psoriasis.

Scalp Psoriasis and Hair Loss

Hair loss is a real but mostly reversible concern. The primary mechanism is telogen effluvium — chronic inflammation from psoriatic plaques prematurely shifts anagen (growing) hair follicles into the telogen (resting/shedding) phase. Rates of telogen hairs as high as 86% have been documented in active psoriatic plaques. Scratching and mechanical trauma from thick scale adhering to hair shafts compound the loss.

The good news: psoriatic hair loss is almost always non-scarring, and hair typically regrows once inflammation is adequately controlled. Scarring (cicatricial) alopecia from psoriasis is a very rare complication of prolonged, severe, undertreated disease.

Full details on this topic are in the dedicated guide: Scalp Psoriasis and Hair Loss.

Living With Scalp Psoriasis: Practical Tips

• Choose gentle hair products. Avoid alcohol-based sprays and harsh detergents that can irritate or trigger the Köbner phenomenon.
• Do not scratch. Scratching thickens plaques (Köbner) and causes bleeding. Keep nails short to reduce damage.
• Soften scale before treatment. Apply a scale-softening oil (coconut, mineral) or salicylic acid product for a few hours before using medicated shampoo. This improves penetration dramatically.
• Apply topicals correctly. Part hair in sections, apply directly to the scalp (not the hair), and leave in for the recommended contact time before rinsing.
• Protect mental health. Visible flaking and scalp soreness carry real psychosocial burden. Dermatological life quality index (DLQI) scores are significantly impaired in scalp psoriasis — this is a valid and recognized reason to escalate treatment.

When to See a Dermatologist

• OTC coal tar or salicylic acid shampoos have been used consistently for 4–6 weeks without meaningful improvement
• Plaques are thick, widespread, or extend significantly beyond the hairline
• Itching is severe enough to disrupt sleep
• Noticeable hair shedding or thinning is occurring
• You are unsure whether the diagnosis is psoriasis, seborrheic dermatitis, or another condition
• Psoriasis is present or suspected elsewhere on the body or in the joints
• Current prescription treatment is not working adequately